[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Sentiment: XX%
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Month: XX% -X%
1-Year High: XXX% on 2025-06-13
1-Year Low: XX% on 2025-06-24
Most Supportive Themes
- GLP-1 Agonists' Broad Benefits: (40%) The potential of GLP-1 receptor agonists in treating various conditions beyond diabetes and obesity, including cardiovascular health, and neurodegenerative diseases.
- GLP-1 Drug Development and Investment: (30%) The increasing interest and investment in GLP-1 drugs and related research, including new studies and developments by companies like Eli Lilly and Amgen.
- Weight Loss and Hormonal Benefits: (15%) The impact of GLP-1 drugs on weight loss and the potential for hormonal benefits, such as increased testosterone levels.
Most Critical Themes
- GLP-1 Drug Risks and Drawbacks: (15%) Concerns about side effects, long-term efficacy, and potential risks associated with GLP-1 drugs and compounded alternatives.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXX | XX% | XXXXX | XX% |
| Total | XXXXX | XX% | XXXXX | XX% | XXXXX | XX% |